BACKGROUND: In Africa, information on dengue is limited to outbreak reports and focused on some countries with continuing transmission in West and East Africa. To estimate the proportion of dengue-positive cases among febrile patients and identify clinical indicators of dengue cases, we conducted passive facility-based fever surveillance in a catchment area population of 70,000 residents of Lambaréné and its surroundings in Gabon. METHODS: Non-malarial febrile patients with current fever or history of fever (≤7 days) between 1 and 55 years of age, were enrolled at Albert Schweitzer Hospital (ASH). Acute (visit 1, day of enrollment) and convalescent blood samples were collected between 10 and 21 days after enrollment. Acute/convalescent samples were tested with IgM/IgG ELISA, and a selected subset of acute samples with RT-PCR. RESULTS: Among 682 non-malarial febrile patients enrolled, 119 (17.4%) were identified as dengue-positive (94 dengue-confirmed and 25 dengue-probable cases). Of these dengue-positive cases, 14 were confirmed with PCR, and based on serotyping, two infections were identified to be DENV-2 and two were DENV-3. The majority of our enrolled patients were <25 years of age and close to 80% of our dengue-positive cases were <15 years of age. In adjusted analyses, retro-orbital pain and abdominal pain were 2.7 and 1.6 times more frequently found among dengue-positive cases, compared to non-dengue cases. CONCLUSION: Lambaréné is not considered dengue-endemic. However, one in six non-malarial febrile episodes was found to be dengue-positive in the study period. Dengue should be considered more frequently in clinicians' diagnosis among non-malarial febrile patients in Lambaréné. Given the lack of data on dengue in Gabon, additional prospective and longitudinal studies would help to further define the burden and patterns of dengue for improved case detection.
BACKGROUND: In Africa, information on dengue is limited to outbreak reports and focused on some countries with continuing transmission in West and East Africa. To estimate the proportion of dengue-positive cases among febrile patients and identify clinical indicators of dengue cases, we conducted passive facility-based fever surveillance in a catchment area population of 70,000 residents of Lambaréné and its surroundings in Gabon. METHODS:Non-malarial febrilepatients with current fever or history of fever (≤7 days) between 1 and 55 years of age, were enrolled at Albert Schweitzer Hospital (ASH). Acute (visit 1, day of enrollment) and convalescent blood samples were collected between 10 and 21 days after enrollment. Acute/convalescent samples were tested with IgM/IgG ELISA, and a selected subset of acute samples with RT-PCR. RESULTS: Among 682 non-malarial febrilepatients enrolled, 119 (17.4%) were identified as dengue-positive (94 dengue-confirmed and 25 dengue-probable cases). Of these dengue-positive cases, 14 were confirmed with PCR, and based on serotyping, two infections were identified to be DENV-2 and two were DENV-3. The majority of our enrolled patients were <25 years of age and close to 80% of our dengue-positive cases were <15 years of age. In adjusted analyses, retro-orbital pain and abdominal pain were 2.7 and 1.6 times more frequently found among dengue-positive cases, compared to non-dengue cases. CONCLUSION: Lambaréné is not considered dengue-endemic. However, one in six non-malarial febrile episodes was found to be dengue-positive in the study period. Dengue should be considered more frequently in clinicians' diagnosis among non-malarial febrilepatients in Lambaréné. Given the lack of data on dengue in Gabon, additional prospective and longitudinal studies would help to further define the burden and patterns of dengue for improved case detection.
Authors: S N Bennett; A J Drummond; D D Kapan; M A Suchard; J L Muñoz-Jordán; O G Pybus; E C Holmes; D J Gubler Journal: Mol Biol Evol Date: 2009-12-04 Impact factor: 16.240
Authors: Haruka Abe; Yuri Ushijima; Marguerite M Loembe; Rodrigue Bikangui; Georgelin Nguema-Ondo; Patrick I Mpingabo; Vahid R Zadeh; Christelle M Pemba; Yohei Kurosaki; Yui Igasaki; Sophia G de Vries; Martin P Grobusch; Selidji T Agnandji; Bertrand Lell; Jiro Yasuda Journal: Int J Infect Dis Date: 2019-12-07 Impact factor: 3.623
Authors: Julian Justin Gabor; Norbert Georg Schwarz; Meral Esen; Peter Gottfried Kremsner; Martin Peter Grobusch Journal: Travel Med Infect Dis Date: 2016-01-29 Impact factor: 6.211
Authors: Antonio Ramos-De La Medina; José M Remes-Troche; María Fernanda González-Medina; María del Mar Anitúa-Valdovinos; Tadeo Cerón; Claudio Zamudio; Aurora Díaz-Vega Journal: Gastroenterol Hepatol Date: 2011-04-06 Impact factor: 2.102
Authors: Michael Ramharter; Ayola A Adegnika; Selidji T Agnandji; Pierre Blaise Matsiegui; Martin P Grobusch; Stefan Winkler; Wolfgang Graninger; Sanjeev Krishna; Maria Yazdanbakhsh; Benjamin Mordmüller; Bertrand Lell; Michel A Missinou; Elie Mavoungou; Saadou Issifou; Peter G Kremsner Journal: Wien Klin Wochenschr Date: 2007 Impact factor: 2.275
Authors: Moritz U G Kraemer; Marianne E Sinka; Kirsten A Duda; Adrian Q N Mylne; Freya M Shearer; Christopher M Barker; Chester G Moore; Roberta G Carvalho; Giovanini E Coelho; Wim Van Bortel; Guy Hendrickx; Francis Schaffner; Iqbal R F Elyazar; Hwa-Jen Teng; Oliver J Brady; Jane P Messina; David M Pigott; Thomas W Scott; David L Smith; G R William Wint; Nick Golding; Simon I Hay Journal: Elife Date: 2015-06-30 Impact factor: 8.140
Authors: Jane P Messina; Oliver J Brady; Thomas W Scott; Chenting Zou; David M Pigott; Kirsten A Duda; Samir Bhatt; Leah Katzelnick; Rosalind E Howes; Katherine E Battle; Cameron P Simmons; Simon I Hay Journal: Trends Microbiol Date: 2014-01-24 Impact factor: 17.079